Outlining Success Stories in Value Demonstration to Private Insurers

Time: 9:30 am
day: Day Two AM

Details:

• The Duchenne Muscular Dystrophy Story: Driving forward access of an approved gene therapy by working with patients and insurers
• Leveraging publications from healthcare professionals around value-based assessments and the therapeutic need
• Addressing the need for consistent messaging between stakeholders in one disease community

Speakers:

Pat Furlong With three decades of expertise in translational medicine Pat Furlong, president and CEO of PPMD, has led ground-breaking research and cultivated meaningful patient engagement strategies, Read more